CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0803

BPC-157 Capsule

Filed under Oral Tablets. The bureau holds 55 laboratory returns for this compound from 19 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

19 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A710.09.910.021 May 202621 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A59.99.910.014 Nov 202516 Apr 2026
Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433X19.39.39.325 Apr 202525 Apr 2025
Glbiochem (Shanghai)CASE #VI-2026-0704A29.18.49.824 May 202624 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A28.97.910.024 May 202624 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A78.87.89.725 May 202625 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A48.78.19.524 May 202624 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A88.26.99.421 May 202621 May 2026
Risynth BioCASE #VI-2026-0672X18.28.28.29 Jun 20259 Jun 2025
Lisa BiopeptideCASE #VI-2026-0131X17.97.97.927 Feb 202527 Feb 2025
Precision Peptide CoCASE #VI-2026-0559X27.65.69.72 Jul 202517 May 2026
Heman Peptide HMCASE #VI-2026-0089X27.47.47.47 May 202524 May 2026
NextGen HealthCASE #VI-2026-0604X17.17.17.113 Feb 202513 Feb 2025
M-PeptidesCASE #VI-2026-0442X17.17.17.125 Apr 202525 Apr 2025
Qing Li PeptideCASE #VI-2026-0469X86.63.28.221 May 202524 May 2026
Haikou Mingheng BiotechnologyCASE #VI-2026-0126X16.56.56.53 Jun 20253 Jun 2025
Evolve BioPepCASE #VI-2026-0755X16.46.46.413 Jun 202513 Jun 2025
Peptide ArkCASE #VI-2026-0350X11.91.91.98 Jul 20258 Jul 2025
PepKitsCASE #VI-2026-0320X10.00.00.027 Feb 202527 Feb 2025

Open any subject to view the batch-level evidence for BPC-157 Capsule alone.